Evidence map›Paper›PMID 39450529›Full record

ReviewInternational journal of molecular medicine2025

Role of Sam68 in different types of cancer (Review).

Carlos Jiménez-Cortegana, Flora Sánchez-Jiménez, Luis De La Cruz-Merino, Víctor Sánchez-Margalet

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Carlos Jiménez-CorteganaDepartment of Medical Biochemistry, Molecular Biology and Immunology, School of Medicine, University of Seville, 41009 Seville, Spain.
Flora Sánchez-JiménezDepartment of Medical Biochemistry, Molecular Biology and Immunology, School of Medicine, University of Seville, 41009 Seville, Spain.
Luis De La Cruz-MerinoDepartment of Medicine, School of Medicine, University of Seville, 41009 Seville, Spain; 4Medical Oncology Service, Virgen Macarena University Hospital, 41009 Seville, Spain.
Víctor Sánchez-MargaletDepartment of Medical Biochemistry, Molecular Biology and Immunology, School of Medicine, University of Seville, 41009 Seville, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Src‑associated in mitosis 68 kDa protein (Sam68) is a protein encoded by the heteronuclear ribonucleoprotein particle K homology (KH) single domain‑containing, RNA‑binding, signal transduction‑associated protein 1 (known as

Indexed as

Adaptor Proteins, Signal TransducingNeoplasmsRNA-Binding ProteinsAnimalsDNA-Binding ProteinsGene Expression Regulation, NeoplasticHumansAdaptor Proteins, Signal TransducingDNA-Binding ProteinsKHDRBS1 protein, humanRNA-Binding Proteinscancercancer‑stem cellsKHDRBS1RNA‑binding proteinSam68tumorigenesis

Identifiers

PMID39450529
PMCPMC11537268

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.